Supporting Clinical Research with Structure and Care
Focused on patient identification and prescreening, while research teams retain full control over clinical decisions.
Why Consent2 Randomize Exists
Clinical trial enrollment does not typically slow down at consent
It begins earlier, within intake and prescreening.
When early conversations are unstructured, qualified patients are lost before they ever reach screening.
Consent2Randomize was built to bring structure to that stage.
Patient recruitment aligned to study criteria
Structured prescreening conversations to confirm eligibility
Clear handoff of qualified participants to your clinical team
Where We Focus
We support the front end of clinical trials
All clinical eligibility and consent remain under site oversight
Evaluating Your Intake and Prescreening Process
If your team is actively enrolling, we can walk through how patient recruitment, intake, and prescreening are currently being handled.
A focused conversation to review your intake process and pinpoint where qualified patients are lost before screening.